Envestnet Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,596
| Closed | -$187K | – | 2947 |
|
|
2018
Q1 | $187K | Sell |
9,596
-10,985
| -53% | -$216K | ﹤0.01% | 1617 |
|
|
2017
Q4 | $343K | Buy |
20,581
+16,976
| +471% | +$311K | ﹤0.01% | 1642 |
|
|
2017
Q3 | $73K | Buy |
3,605
+846
| +31% | +$16.2K | ﹤0.01% | 2181 |
|
|
2017
Q2 | $45K | Sell |
2,759
-275
| -9% | -$4.06K | ﹤0.01% | 2391 |
|
|
2017
Q1 | $39K | Buy |
3,034
+356
| +13% | +$4.3K | ﹤0.01% | 2500 |
|
|
2016
Q4 | $36K | Sell |
2,678
-798
| -23% | -$13.6K | ﹤0.01% | 2534 |
|
|
2016
Q3 | $82K | Sell |
3,476
-204
| -6% | -$5.48K | ﹤0.01% | 2412 |
|
|
2016
Q2 | $106K | Sell |
3,680
-218
| -6% | -$7.11K | ﹤0.01% | 2408 |
|
|
2016
Q1 | $125K | Sell |
3,898
-146
| -4% | -$5.13K | ﹤0.01% | 2301 |
|
|
2015
Q4 | $173K | Sell |
4,044
-679
| -14% | -$27.1K | ﹤0.01% | 2107 |
|
|
2015
Q3 | $166K | Sell |
4,723
-318
| -6% | -$14.3K | ﹤0.01% | 2113 |
|
|
2015
Q2 | $231K | Sell |
5,041
-1,046
| -17% | -$49.6K | ﹤0.01% | 2071 |
|
|
2015
Q1 | $285K | Buy |
6,087
+5,774
| +1,845% | +$230K | ﹤0.01% | 1808 |
|
|
2014
Q4 | $10K | Sell |
313
-1,058
| -77% | -$31K | ﹤0.01% | 1980 |
|
|
2014
Q3 | $33K | Sell |
1,371
-19,005
| -93% | -$487K | ﹤0.01% | 1694 |
|
|
2014
Q2 | $611K | Sell |
20,376
-407
| -2% | -$11K | 0.01% | 709 |
|
|
2014
Q1 | $549K | Sell |
20,783
-345
| -2% | -$8.62K | 0.01% | 631 |
|
|
2013
Q4 | $531K | Sell |
21,128
-1,202
| -5% | -$26.8K | 0.01% | 617 |
|
|
2013
Q3 | $457K | Buy |
22,330
+39
| +0.2% | +$805 | 0.01% | 626 |
|
|
2013
Q2 | $444K | Buy |
+22,291
| New | +$396K | 0.01% | 614 |
|
Envestnet Asset Management's IPXL Position: Q2 2018 in Review
Envestnet Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 9,596 shares — an estimated $187K sold.
Envestnet Asset Management first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $611K in Q2 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Envestnet Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Envestnet Asset Management sold 9,596 Impax Laboratories, Inc. shares in Q2 2018, an estimated $187K.
- Envestnet Asset Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Envestnet Asset Management's Impax Laboratories, Inc. position peaked at $611K in Q2 2014.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Envestnet Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.